105 related articles for article (PubMed ID: 16887106)
1. Fmrp is required for the establishment of the startle response during the critical period of auditory development.
Yun SW; Platholi J; Flaherty MS; Fu W; Kottmann AH; Toth M
Brain Res; 2006 Sep; 1110(1):159-65. PubMed ID: 16887106
[TBL] [Abstract][Full Text] [Related]
2. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
3. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.
Musumeci SA; Calabrese G; Bonaccorso CM; D'Antoni S; Brouwer JR; Bakker CE; Elia M; Ferri R; Nelson DL; Oostra BA; Catania MV
Exp Neurol; 2007 Jan; 203(1):233-40. PubMed ID: 17007840
[TBL] [Abstract][Full Text] [Related]
4. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
5. Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.
Paylor R; Yuva-Paylor LA; Nelson DL; Spencer CM
Behav Neurosci; 2008 Dec; 122(6):1371-7. PubMed ID: 19045956
[TBL] [Abstract][Full Text] [Related]
6. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.
Baker KB; Wray SP; Ritter R; Mason S; Lanthorn TH; Savelieva KV
Genes Brain Behav; 2010 Aug; 9(6):562-74. PubMed ID: 20398059
[TBL] [Abstract][Full Text] [Related]
7. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.
Levenga J; Hayashi S; de Vrij FM; Koekkoek SK; van der Linde HC; Nieuwenhuizen I; Song C; Buijsen RA; Pop AS; Gomezmancilla B; Nelson DL; Willemsen R; Gasparini F; Oostra BA
Neurobiol Dis; 2011 Jun; 42(3):311-7. PubMed ID: 21316452
[TBL] [Abstract][Full Text] [Related]
8. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
[TBL] [Abstract][Full Text] [Related]
9. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA
Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225
[TBL] [Abstract][Full Text] [Related]
10. Corticosterone response to acute stress in a mouse model of Fragile X syndrome.
Markham JA; Beckel-Mitchener AC; Estrada CM; Greenough WT
Psychoneuroendocrinology; 2006 Jul; 31(6):781-5. PubMed ID: 16621323
[TBL] [Abstract][Full Text] [Related]
11. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures.
Pacey LK; Heximer SP; Hampson DR
Mol Pharmacol; 2009 Jul; 76(1):18-24. PubMed ID: 19351745
[TBL] [Abstract][Full Text] [Related]
12. Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice.
Shang Y; Wang H; Mercaldo V; Li X; Chen T; Zhuo M
J Neurochem; 2009 Nov; 111(3):635-46. PubMed ID: 19659572
[TBL] [Abstract][Full Text] [Related]
13. The developmental roles of FMRP.
Till SM
Biochem Soc Trans; 2010 Apr; 38(2):507-10. PubMed ID: 20298211
[TBL] [Abstract][Full Text] [Related]
14. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland PW; Wang Y; Rosner B; Shimizu T; Balleine BW; Dykens EM; Ornitz EM; Silva AJ
Mol Psychiatry; 2004 Apr; 9(4):417-25. PubMed ID: 14981523
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome.
Pacey LK; Doering LC
Glia; 2007 Nov; 55(15):1601-9. PubMed ID: 17823967
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
17. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
[TBL] [Abstract][Full Text] [Related]
18. Mouse model of fragile X syndrome: behavioral and hormonal response to stressors.
Nielsen DM; Evans JJ; Derber WJ; Johnston KA; Laudenslager ML; Crnic LS; Maclean KN
Behav Neurosci; 2009 Jun; 123(3):677-86. PubMed ID: 19485574
[TBL] [Abstract][Full Text] [Related]
19. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
20. Fragile X mice develop sensory hyperreactivity to auditory stimuli.
Chen L; Toth M
Neuroscience; 2001; 103(4):1043-50. PubMed ID: 11301211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
